Ironwood Stock Hits New 52-Week Low (IRWD)

NEW YORK ( TheStreet) -- Ironwood Pharmaceuticals (Nasdaq: IRWD) hit a new 52-week low Tuesday as it is currently trading at $9.97, below its previous 52-week low of $10 with 12,527 shares traded as of 9:46 a.m. ET. Average volume has been 266,600 shares over the past 30 days.

Ironwood has a market cap of $1.1 billion and is part of the health care sector and health services industry. Shares are down 2.5% year to date as of the close of trading on Monday.

Ironwood Pharmaceuticals, Inc. discovers, develops, and commercializes medicines targeting therapeutic needs.
  • Practice your IRWD trading strategies and win cash in our stock game.

TheStreet Ratings rates Ironwood as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and deteriorating net income. You can view the full Ironwood Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

null

More from Markets

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

GE Confirms $11.1 Billion Transportation Merger With Wabtec

GE Confirms $11.1 Billion Transportation Merger With Wabtec